CPI-182

N/A

Report date: 2024/05/11 18:36:10

Base Information

Drug NameCPI-182
Drug Alias NameCPI-182
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-CXCR2
TargetsC-X-C motif chemokine receptor 2
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Inactive CompaniesMonash University
Active IndicationsNeoplasms
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A